We are live on ! Find out more
KPRX icon

Kiora Pharmaceuticals
KPRX

9 hedge funds and large institutions have $8.47M invested in Kiora Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more capital invested

Capital invested by funds: $4.45M → $8.47M (+$4.01M)

0.16% more ownership

Funds ownership: 0.01% → 0.16% (+0.16%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

44% less funds holding

Funds holding: 16 → 9 (-7)

88% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 8

Holders
9
Holders Change
-7
Holders Change %
-43.75%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$1.93M
2
Victory Capital Management
Victory Capital Management
Texas
+$1.15K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$53K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$39K
3
PAM
Panagora Asset Management
Massachusetts
-$23K
4
UBS Group
UBS Group
Switzerland
-$11.5K
5
TSS
Two Sigma Securities
New York
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$8.44M +$1.93M +1,680 +51%
US Bancorp
2
US Bancorp
Minnesota
$9K – – –
GSWM
3
Golden State Wealth Management
California
$6K – – –
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$4K – – –
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$3K – – –
UBS Group
6
UBS Group
Switzerland
$2K -$11.5K -10 -91%
LTFS
7
Ladenburg Thalmann Financial Services
Florida
$2K – – –
Morgan Stanley
8
Morgan Stanley
New York
$1K – – –
Victory Capital Management
9
Victory Capital Management
Texas
$1K +$1.15K +1 New
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
– -$53K -41 Closed
Vanguard Group
11
Vanguard Group
Pennsylvania
– -$39K -30 Closed
PAM
12
Panagora Asset Management
Massachusetts
– -$23K -18 Closed
TSS
13
Two Sigma Securities
New York
– -$10K -8 Closed
AG
14
Advisor Group
Arizona
– -$3K -3 Closed
Northern Trust
15
Northern Trust
Illinois
– -$3K -3 Closed
VF
16
Virtu Financial
New York
– -$3K -3 Closed
WS
17
Wedbush Securities
California
– -$4K -3 Closed

KPRX Hedge Fund Activity: Q3 2019 in Review

9 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Kiora Pharmaceuticals (KPRX) for Q3 2019, worth a combined $8.47M — up 90% from $4.45M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of KPRX and 1 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Armistice Capital, adding an estimated $1.93M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $53K sold.

  • 9 institutional investors held Kiora Pharmaceuticals (KPRX) as of Q3 2019, down from 16 in Q2 2019.
  • Funds reported $8.47M of Kiora Pharmaceuticals stock for Q3 2019, up 90% quarter-over-quarter.
  • 1 fund opened new Kiora Pharmaceuticals positions in Q3 2019 and 8 closed out, a net change of -7 holders.
  • The largest Kiora Pharmaceuticals buyer in Q3 2019 was Armistice Capital, an estimated $1.93M added.
  • The largest Kiora Pharmaceuticals seller in Q3 2019 was Susquehanna International Group, an estimated $53K sold.

Based on aggregated 13F filings for Q3 2019.